Novo Nordisk strikes $1bn deal for Lexicon’s oral weight problems drug
The weight problems therapy market is projected to achieve $206.5bn by 2031, as per GlobalData. Credit score: Cunaplus_M.Faba through Getty...
Pharmaceutical Updates
Amgen loses battle with Colorado over prescription drug affordability board
In a blow to the pharmaceutical trade, a U.S. courtroom decide dominated {that a} Colorado state board can proceed with...
Pharma R&D Returns Develop Once more, However Deloitte Warns Progress is ‘Fragile’
For the second yr in a row, the inner charge of return for pharmaceutical R&D on the prime 20 corporations...
How bioconjugation is unlocking new drug improvement
Environment friendly scale-up of bioconjugate synthesis and manufacturing is essential for profitable drug improvement. Picture credit score: Gorodenkoff through Shutterstock...
‘Black field’ pharma, telehealth offers elevate battle of curiosity points
In latest months, a new form of partnership between telehealth corporations and pharmaceutical producers has come underneath scrutiny over considerations...
GLP-1 Injectables Will Quickly Be Joined by Orals. Is the Business Able to Scale?
As Novo Nordisk and Eli Lilly start to place the challenges they confronted stocking their blockbuster weight reduction medication behind...
Novo Nordisk earmarks $2bn for Chinese language “triple G” weight reduction shot
Novo Nordisk’s newly acquired asset has already produced optimistic information in a randomised Part Ib trial in China. Picture credit...
Can philanthropy rescue struggling small biotechs?
Morning. Immediately, we’re having a look on the profound impression of funding cuts on most cancers analysis beneath the Trump...
6 Therapies on the Horizon for Spinal Muscular Atrophy
The final decade has basically modified how clinicians deal with spinal muscular atrophy. In 2016, Biogen’s Spinraza grew to become...
European businesses meet up with speedier regulatory pathways for CGTs within the US
DNA Helix. Credit score: koto_feja by way of Getty Photos Though the regulatory panorama for superior remedy medicinal merchandise (ATMPs)...
STAT+: Up and down the ladder: The newest comings and goings
Employed somebody new and thrilling? Promoted a rising star? Lastly solved that hard-to-fill spot? Share the information with us, and...
J&J Joins Pharma Friends With $55B US Manufacturing Enhance Following Trump’s Tariff Threats
President Donald Trump’s demand for U.S. manufacturing has introduced round one other Huge Pharma. Johnson & Johnson adopted within the...
China conditionally approves Hutchmed’s Tazverik for FL
The bridging examine’s primary goal is to evaluate the target response charge of the remedy in topics with R/R FL...
Pfizer’s chief strategist talks about weight problems medicine, R&D and extra
NEW YORK — In his first public feedback, Pfizer’s new innovation chief — as soon as a Wall Avenue analyst...
Novartis’ Intrathecal Zolgensma Efficient in Older Youngsters
Six years in the past, the FDA permitted Novartis’ Zolgensma as the primary gene remedy for youngsters beneath two years...
